UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FO084APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION AND ORGAN DAMAGE IN CKD BY ALTERNATIVE INFLAMMASOME ACTIVATION VIA A NOVEL PATHWAY

Nephrology, dialysis, transplantation, 2019-06, Vol.34 (Supplement_1)

2019

Volltextzugriff (PDF)

Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study

Vascular pharmacology, 2019-05, Vol.116, p.8-15

2019

Volltextzugriff (PDF)

Cardiovascular risk algorithms in primary care: Results from the DETECT study

Scientific reports, 2019-01, Vol.9 (1), p.1101-1101, Article 1101

2019

Volltextzugriff (PDF)

Gesundheitsökonomische Aspekte der Verschreibung von PCSK9-Hemmern

Cardiovasc, 2018-12, Vol.18 (6), p.34-37

2018

Volltextzugriff (PDF)

Testosterone is not associated with traits of optimism or pessimism: Observational evidence from the prospective DETECT study

PloS one, 2018-11, Vol.13 (11), p.e0207870-e0207870

2018

Volltextzugriff (PDF)

Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry

Atherosclerosis, 2018-10, Vol.277, p.314-322

2018

Volltextzugriff (PDF)

Schon niedrige Statindosis potenziert PCSK9i-Effekt

Cardiovasc, 2018-09, Vol.18 (4), p.22-23

2018

Volltextzugriff (PDF)

Case report—Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia

Journal of clinical lipidology, 2018-07, Vol.12 (4), p.868-871

2018

Volltextzugriff (PDF)

Longitudinal change instead of baseline testosterone predicts depressive symptoms

Psychoneuroendocrinology, 2018-03, Vol.89, p.7-12

2018

Volltextzugriff (PDF)

CaRe high – Cascade screening and registry for high cholesterol in Germany

Atherosclerosis. Supplements, 2017-11, Vol.30, p.72-76

2017

Volltextzugriff (PDF)

Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study

Atherosclerosis, 2017-11, Vol.266, p.24-30

2017

Volltextzugriff (PDF)

HDL cholesterol: reappraisal of its clinical relevance

Clinical research in cardiology, 2017-09, Vol.106 (9), p.663-675

2017

Volltextzugriff (PDF)

Cost-effectiveness of PCSK9 inhibitor therapy for patients with stable CAD in Germany

Atherosclerosis, 2017-08, Vol.263, p.e160-e161

2017

Volltextzugriff (PDF)

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders

Multiple sclerosis, 2017-07, Vol.23 (8), p.1092-1103

2017

Volltextzugriff (PDF)

Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease

European heart journal, 2017-05, Vol.38 (20), p.1597-1607

2017

Volltextzugriff (PDF)

Propeptide big-endothelin, N-terminal-pro brain natriuretic peptide and mortality. The Ludwigshafen risk and cardiovascular health (LURIC) study

Biomarkers, 2017-05, Vol.22 (3-4), p.315-320

2017

Volltextzugriff (PDF)

MP354SYMMETRIC DIMETHYLARGININE, HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii556-iii557

2017

Volltextzugriff (PDF)

MO031APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE BY ACTIVATING THE NALP3 INFLAMMASOME VIA A NOVEL MOLECULAR PATHWAY

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii55-iii55

2017

Volltextzugriff (PDF)

Chronic kidney disease in primary care in Germany

Journal of public health, 2017-04, Vol.25 (2), p.223-230

2017

Volltextzugriff (PDF)

Erratum to: LDL-Cholesterol: Standards of Treatment 2016: A German Perspective

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016-12, Vol.16 (6), p.475-476

2016

Volltextzugriff (PDF)

Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia

Atherosclerosis, 2016-10, Vol.253, p.88-93

2016

Volltextzugriff (PDF)

LDL-Cholesterol: Standards of Treatment 2016: A German Perspective

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016-10, Vol.16 (5), p.323-336

2016

Volltextzugriff (PDF)

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization

Arteriosclerosis, thrombosis, and vascular biology, 2016-09, Vol.36 (9), p.2019-2027

2016

Volltextzugriff (PDF)

SP280HIGH-DENSITY LIPOPROTEIN - SYMMETRIC DIMETHYLARGININE - A CKD-SPECIFIC ASSOCIATION PROMOTING PREMATURE CARDIOVASCULAR DISEASE

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i181-i181

2016

Volltextzugriff (PDF)

26 – 50 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(58)
Humans
(52)
Female
(34)
Male
(33)
Middle Aged
(33)
Risk Factors
(27)
Adult
(23)
Aged
(23)
Cardiovascular System & Cardiology
(20)
Cardiac & Cardiovascular Systems
(15)
Cardiovascular Disease
(14)
Cardiovascular Diseases
(14)
Prospective Studies
(14)
Biological And Medical Sciences
(11)
Animals
(10)
Cardiovascular Diseases - Epidemiology
(10)
Cholesterol
(10)
General & Internal Medicine
(10)
Medical Sciences
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FO084APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION AND ORGAN DAMAGE IN CKD BY ALTERNATIVE INFLAMMASOME ACTIVATION VIA A NOVEL PATHWAY

Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study

Cardiovascular risk algorithms in primary care: Results from the DETECT study

Gesundheitsökonomische Aspekte der Verschreibung von PCSK9-Hemmern

Testosterone is not associated with traits of optimism or pessimism: Observational evidence from the prospective DETECT study

Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry

Schon niedrige Statindosis potenziert PCSK9i-Effekt

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

Case report—Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia

Longitudinal change instead of baseline testosterone predicts depressive symptoms

CaRe high – Cascade screening and registry for high cholesterol in Germany

Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study

HDL cholesterol: reappraisal of its clinical relevance

Cost-effectiveness of PCSK9 inhibitor therapy for patients with stable CAD in Germany

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders

Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease

Propeptide big-endothelin, N-terminal-pro brain natriuretic peptide and mortality. The Ludwigshafen risk and cardiovascular health (LURIC) study

MP354SYMMETRIC DIMETHYLARGININE, HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE

MO031APOLIPOPROTEIN C3 INDUCES SYSTEMIC INFLAMMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE BY ACTIVATING THE NALP3 INFLAMMASOME VIA A NOVEL MOLECULAR PATHWAY

Chronic kidney disease in primary care in Germany

Erratum to: LDL-Cholesterol: Standards of Treatment 2016: A German Perspective

Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia

LDL-Cholesterol: Standards of Treatment 2016: A German Perspective

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization

SP280HIGH-DENSITY LIPOPROTEIN - SYMMETRIC DIMETHYLARGININE - A CKD-SPECIFIC ASSOCIATION PROMOTING PREMATURE CARDIOVASCULAR DISEASE

Suchergebnisse filtern